E-Cadherin Upregulation as a Therapeutic Goal in Cancer Treatment

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 5, 2008-01 ,pp. : 496-518

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Therapeutic Targets for Acute Pancreatitis and Associated Multiple Organ Dysfunction Syndrome

By  

Current Drug Targets. Inflammation & Allergy, Vol. 1, Iss. 4, 2002-12 ,pp. : 343-351

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanisms and Therapeutic Targets of microRNA-associated Chemoresistance in Epithelial Ovarian Cancer

By  

Current Cancer Drug Targets, Vol. 16, Iss. 5, 2016-06 ,pp. : 429-441

Bentham Science Publishers

Access to resources Recommend Favorite

The Biphasic Expression Pattern of miR-200a and E-cadherin in Epithelial Ovarian Cancer and its Correlation with Clinicopathological Features

By  

Current Pharmaceutical Design, Vol. 20, Iss. 11, 2014-04 ,pp. : 1888-1895

Bentham Science Publishers

Access to resources Recommend Favorite

Enhancement of tamoxifen-induced E-cadherin function by Ca 2+ channel antagonists in human breast cancer MCF7/6 cells

By Charlier C.   Bruyneel E.   Lechanteur C.   Bracke M.   Mareel M.   Castronovo V.  

European Journal of Pharmacology, Vol. 317, Iss. 2, 1996-12 ,pp. : 413-416

Elsevier

Access to resources Recommend Favorite